Evidence of the role of GLP-1RAs in managing psoriatic disease comorbidities GLP1-RAs play a pivotal role in managing comorbidities associated with PsD including T2DM, obesity and CV events
Underpinned by genetic and nutritional counseling, the integration of genetic parameters influencing the response to dietary components, type of exercise, different pharmacotherapies and behavioral traits, such as adherence and reward eating, as well as their interactions, will enable further personalization and greater potential for improved pharmacotherapy outcomes in patients with obesity (73, 8083)
( Figure 1 ) considering an even distribution of body weight (788 220 kg), body condition score (2.5-4.75) and number of lactation (2-5 lactations)
mucosal nevi, which are moles on the mucus membranes
However, a clinical trial utilizing nivolumab, a PD-1 inhibitor, in patients with metastatic castration-resistant prostate cancer (mCRPC) failed to demonstrate notable objective response rates (Topalian et al., 2012)
When testosterone levels fall below a healthy range, the condition is often referred to as low T